Metabolomic Proï¬ling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells
2017 | Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK; [email protected] (S.A.); [email protected] (J.T.); [email protected] (L.C.Y.); [email protected] (C.J.C.); [email protected] (V.A.F.) 2 Depar | Pp. 2-18
 Melittin, the main peptide present in bee venom, has been proposed as having potential for anticancer therapy; the addition of melittin to cisplatin, a ï¬rst line treatment for ovarian cancer, may increase the therapeutic response in cancer treatment via s...